Institution
Medicines for Malaria Venture
Recent research
- Health & MedicineOpen access
Radical cure of Plasmodium vivax malaria remains a major challenge in endemic countries. New treatment options add opportunities but also increase complexity of policy decisions. Malaria treatment policies are often shaped by World Health Organisation (WHO) guidance, limiting sco...
- Health & MedicineOpen access
Abstract Background The 8-aminoquinoline primaquine is used as a single low dose with antimalarial treatment to reduce malaria transmission. An alternative 8-aminoquinoline, tafenoquine has a substantially longer half-life and may therefore provide more sustained transmission-blo...
- Health & MedicineOpen access
Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase
ABSTRACT Malaria remains one of the major threats to human health. Breakthrough drugs with high potency and low resistance risk are needed to combat the ever-increasing resistance to currently deployed antimalarials. Here, we explore a series of 4-aminoquinazoline-based sulfonami...
- Health & MedicineOpen access
Abstract Malaria remains a major cause of morbidity and mortality, particularly among young children, in endemic regions such as sub-Saharan Africa and Southeast Asia. Moreover, the emerging resistance of Plasmodium parasites to front-line therapeutics underscores the need for ne...
- Health & Medicine
The Governance Gap: Democratizing Drug Development Through Decision Architecture
Drug development is most exposed to governance failure where it can least afford it, in global health. The field has more predictive power than at any point in its history and roughly the same failure rate it had a decade ago. We argue that this paradox persists because the field...